Machine learning (ML) significantly enhances the early prediction and management of Alzheimer's disease (AD) by analyzing complex medical data to identify biomarkers and risk factors, thereby improving diagnostic accuracy, enabling personalized treatment plans, and contributing to the development of targeted therapies and preventive strategies.
